Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy
Completed
N/A
Interventional Study
Uterine Fibroids (Leiomyoma)
Myomectomy
Myomectomy; Surgical Blood Loss
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60
- Sponsor
- Alexandria University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The current study is a multiple-arm, single blinded, and controlled randomized trial. It will be conducted in two gynecological endoscopy centers: • ElShatby University Hospital, a tertiary level hospital in Alexandria, Egypt. • Al-Madina Women Hospital, A specialized hospital of Obstetrics and Gynecology, Alexandria, Egypt. Patient selection: women with uterine leiomyomata and planning for laparo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* women with uterine fibroids and complaining of either abnormal uterine bleeding, infertility, urinary or rectosigmoid pressure manifestations.
* Fibroid size from 3 - 10 cm in diameter and with
* a maximum number of 3 fibroids.
Exclusion Criteria:
* contraindication to pneum…
Contacts
No contact information available.